Biotie Therapies Corp.;The University of Birmingham
发明人:
WESTON, Christopher,CLARIDGE, Lee Charles,ADAMS, David,SMITH, David,WESTERLUND, Nina,PIHLAVISTO, Marjo,ÖSTERMAN, Thua
申请号：
MEP201821
公开号：
ME02999B
申请日:
2018.02.28
申请国别(地区):
ME
年份:
2018
代理人:
摘要：
The present invention relates to inhibitors of VAP-1 and their use as medicaments in treating fibrotic conditions. Furthermore, the present invention relates to a method of diagnosing a fibrotic condition on the basis of elevated level of soluble VAP-1 or SSAO activity in a bodily fluid, and to a kit for use in said diagnostic method.
